(Q43166491)

English

Integration of autologous dendritic cell-based immunotherapy in the primary treatment for patients with newly diagnosed glioblastoma multiforme: a pilot study

scientific article published on 10 February 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

Integration of autologous dendritic cell-based immunotherapy in the primary treatment for patients with newly diagnosed glioblastoma multiforme: a pilot study (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Steven De Vleeschouwer

12

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

5

object named as

Raf Sciot

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

9

object named as

Laurence Claes

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

author name string

Hilko Ardon

1

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

Stefaan Van Gool

2

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

Isabel Spencer Lopes

3

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

Wim Maes

4

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

Guido Wilms

6

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

Philippe Demaerel

7

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

Patricia Bijttebier

8

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

Jan Goffin

10

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

Frank Van Calenbergh

11

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

publication date

10 February 2010

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

Journal of Neuro-Oncology

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

99

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

261-272

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

https://scigraph.springernature.com/pub.10.1007/s11060-010-0131-y

0 references

Transient local response and persistent tumor control in a child with recurrent malignant glioma: treatment with combination therapy including dendritic cell therapy. Case report

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0131-Y

21 January 2018

Thymic CD8+ T Cell Production Strongly Influences Tumor Antigen Recognition and Age-Dependent Glioma Mortality

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0131-Y

21 January 2018

Dendritic cells are essential for priming but inefficient for boosting antitumour immune response in an orthotopic murine glioma model

1 reference

https://pubmed.ncbi.nlm.nih.gov/20146084

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Marrying immunotherapy with chemotherapy: why say IDO?

1 reference

https://pubmed.ncbi.nlm.nih.gov/20146084

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of a patient by vaccination with autologous dendritic cells pulsed with allogeneic major histocompatibility complex class I-matched tumor peptides. Case Report

1 reference

https://pubmed.ncbi.nlm.nih.gov/20146084

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alternating chemo-immunotherapy with temozolomide and low-dose interleukin-2 in patients with metastatic melanoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20146084

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse

1 reference

https://pubmed.ncbi.nlm.nih.gov/20146084

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

T-cell reconstitution and expansion after hematopoietic stem cell transplantation: 'T' it up!

1 reference

https://pubmed.ncbi.nlm.nih.gov/20146084

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immune and clinical responses in patients with metastatic melanoma to CD34(+) progenitor-derived dendritic cell vaccine

1 reference

https://pubmed.ncbi.nlm.nih.gov/20146084

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Control of Foxp3+ CD25+CD4+ regulatory cell activation and function by dendritic cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20146084

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20146084

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bone marrow-derived dendritic cells pulsed with a tumor-specific peptide elicit effective anti-tumor immunity against intracranial neoplasms

1 reference

https://pubmed.ncbi.nlm.nih.gov/20146084

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pediatric supratentorial high-grade gliomas.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20146084

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radiation-induced, immunologically mediated regression of an established tumor as an example of successful therapeutic immunomanipulation. Preferential elimination of suppressor T cells allows sustained production of effector T cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/20146084

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vaccination of malignant glioma patients with peptide-pulsed dendritic cells elicits systemic cytotoxicity and intracranial T-cell infiltration

1 reference

https://pubmed.ncbi.nlm.nih.gov/20146084

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dendritic cell vaccination in glioblastoma patients induces systemic and intracranial T-cell responses modulated by the local central nervous system tumor microenvironment

1 reference

https://pubmed.ncbi.nlm.nih.gov/20146084

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monocyte release and plasma levels of interleukin-6 in patients irradiated for cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20146084

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Munster Heidelberg Abilities Scale--a measuring instrument for global comparison of illness sequelae]

1 reference

https://pubmed.ncbi.nlm.nih.gov/20146084

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Active immunotherapy for advanced intracranial murine tumors by using dendritic cell-tumor cell fusion vaccines.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20146084

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Histopathology, classification, and grading of gliomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/20146084

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/20146084

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20146084

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Validation of the EORTC QLQ-C30 quality of life questionnaire through combined qualitative and quantitative assessment of patient-observer agreement

1 reference

https://pubmed.ncbi.nlm.nih.gov/20146084

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Surgery and adjuvant dendritic cell-based tumour vaccination for patients with relapsed malignant glioma, a feasibility study

1 reference

https://pubmed.ncbi.nlm.nih.gov/20146084

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Results of a phase I clinical trial of vaccination of glioma patients with fusions of dendritic and glioma cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20146084

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

1 reference

https://pubmed.ncbi.nlm.nih.gov/20146084

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Postoperative adjuvant dendritic cell-based immunotherapy in patients with relapsed glioblastoma multiforme

1 reference

https://pubmed.ncbi.nlm.nih.gov/20146084

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma

1 reference

https://pubmed.ncbi.nlm.nih.gov/20146084

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytotoxic T cell targeting of TRP-2 sensitizes human malignant glioma to chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20146084

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

DC vaccination with anti-CD25 treatment leads to long-term immunity against experimental glioma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20146084

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemotherapy resistance of glioblastoma stem cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/20146084

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

?-Irradiation facilitates the expression of adoptive immunity against established tumors by eliminating suppressor T cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/20146084

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight-drugs-in-1-day regimen. Childrens Cancer Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20146084

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modulation of T-cell function by gliomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/20146084

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymphocyte targeting of the central nervous system: a review of afferent and efferent CNS-immune pathways

1 reference

https://pubmed.ncbi.nlm.nih.gov/20146084

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased regulatory T-cell fraction amidst a diminished CD4 compartment explains cellular immune defects in patients with malignant glioma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20146084

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dendritic cell vaccination in patients with malignant gliomas: current status and future directions.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20146084

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical responsiveness of glioblastoma multiforme to chemotherapy after vaccination

1 reference

https://pubmed.ncbi.nlm.nih.gov/20146084

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preferential migration of regulatory T cells mediated by glioma-secreted chemokines can be blocked with chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20146084

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical evaluation of dendritic cell vaccination for patients with recurrent glioma: results of a clinical phase I/II trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/20146084

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vivo bioluminescence imaging in an experimental mouse model for dendritic cell based immunotherapy against malignant glioma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20146084

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Autologous glioma cell vaccine admixed with interleukin-4 gene transfected fibroblasts in the treatment of patients with malignant gliomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/20146084

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cure of established, intracerebral rat gliomas induced by therapeutic immunizations with tumor cells and purified APC or adjuvant IFN-gamma treatment.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20146084

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/20146084

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Uptake and presentation of malignant glioma tumor cell lysates by monocyte-derived dendritic cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20146084

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of treatment results for recurrent malignant gliomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/20146084

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vaccination of glioma patients with fusions of dendritic and glioma cells and recombinant human interleukin 12.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20146084

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

1 reference

https://pubmed.ncbi.nlm.nih.gov/20146084

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20146084

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dendritic cell therapy of high-grade gliomas.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20146084

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

1 reference

https://pubmed.ncbi.nlm.nih.gov/20146084

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The generation of anti-tumoral cells using dentritic cells from the peripheral bloood of patients with malignant brain tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/20146084

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prerequisites for the immunotherapy of cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20146084

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Maintaining the norm: T-cell homeostasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20146084

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vaccination of recurrent glioma patients with tumour lysate-pulsed dendritic cells elicits immune responses: results of a clinical phase I/II trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/20146084

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Persistent IL-10 production is required for glioma growth suppressive activity by Th1-directed effector cells after stimulation with tumor lysate-loaded dendritic cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20146084

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Failure of cancer vaccines: the significant limitations of this approach to immunotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20146084

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synergy between chemotherapy and immunotherapy in the treatment of established murine solid tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/20146084

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Results of a phase I dendritic cell vaccine trial for malignant astrocytoma: potential interaction with adjuvant chemotherapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20146084

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vaccination elicits correlated immune and clinical responses in glioblastoma multiforme patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/20146084

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/20146084

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11060-010-0131-Y

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43166491&oldid=1982760948"